VANESSA MISCHLER: Open Payments
NPI 1104508993 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,951 in 182 payments from 18 companies in 2025. Trend: 2023 $667 · 2024 $3,169 · 2025 $2,951
Food & beverage: $2,946Education: $5
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 34 | $535 |
| UCB, Inc. | 15 | $343 |
| ABBVIE INC. | 33 | $315 |
| Galderma Laboratories, L.P. | 27 | $293 |
| Regeneron Healthcare Solutions, Inc. | 19 | $267 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 6 | $208 |
| E.R. Squibb & Sons, L.L.C. | 11 | $186 |
| Organon LLC | 8 | $181 |
| Lilly USA, LLC | 3 | $150 |
| GENZYME CORPORATION | 9 | $136 |
Products named: TREMFYA, DUPIXENT, Bimzelx, NEMLUVIO, RINVOQ, Sotyktu, VTAMA, SILIQ.
Industry payments across IN — which companies pay providers there.
